Navigating the oncology drug discovery and development process with programmes supported by the National Institutes...

Area of Science:

• Pharmacology and Drug Development
• Biomedical Research
• Translational Science

Background:

• Translating laboratory drug discoveries into clinical applications faces significant hurdles, including funding shortages and unclear project direction.
• Understanding a drug's efficacy and limitations is crucial but often challenging during early development.
• The National Institutes of Health (NIH) recognizes these obstacles in the drug development pipeline.

Purpose of the Study:

• To explore the diverse platforms and resources provided by the NIH for drug development.
• To guide researchers on effectively utilizing NIH resources to expedite the translation of drug discoveries.
• To address the challenges inherent in moving from basic research to clinical use.

Main Methods:

• Review of NIH programs and databases relevant to drug discovery and development.
• Identification of resources supporting preclinical and clinical stages of therapeutic evaluation.
• Analysis of how researchers can access and utilize NIH expert networks and funding opportunities.

Main Results:

• The NIH provides access to curated databases covering drug discovery, target identification, genomics, proteomics, and clinical data.
• Key NIH programs like the Developmental Therapeutics Program and Cancer Therapy Evaluation Program support different phases of drug development.
• Available resources include funding, scientific expertise, and services to bridge research gaps.

Conclusions:

• The NIH offers a comprehensive suite of resources to facilitate drug development.
• Researchers can significantly accelerate their drug development timelines by strategically engaging with NIH platforms and programs.
• Leveraging NIH support is essential for overcoming translational challenges in drug discovery.